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Abstract
Molecular imaging techniques now allow recognition of early biochemical, physiological, and
anatomical Changes before manifestation of gross pathological changes. Photoacoustic imaging
represents a novel non-ionizing detection technique that combines the advantages of optical and
ultrasound imaging Noninvasive photoacoustic tomography (PAT) imaging in combination with
nanoparticle-based contrast agents show promise in improved detection and diagnosis of cardio-
vascular and cancer related diseases. In this report, a novel strategy is introduced to achieve self-
assembled colloidal gold nanorods, which are constrained to the vasculature. Gold nanorods (2–4
nm) were incorporated into the core of self-assembled lipid-encapsulated nanoparticles (sGNR)
(~130 nm), providing more than hundreds of gold atoms per nanoparticle of 20% colloid
suspension. The physico-chemical characterization in solution and anhydrous state with analytical
techniques demonstrated that the particles were spherical and highly mono dispersed. In addition
to the synthesis and characterization, sensitive near-infrared photoacoustic detection was
impressively demonstrated in vitro.
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1. INTRODUCTION
Nanotechnology is permeating through the realms of science.1–3 In the biomedical arena
nanoparticles present a multiplicity of opportunity to diagnose pathology earlier or to deliver
drug locally with greater safety margins. These image-guided therapeutic systems, so called
theranostics, constitute a major pathway toward the concept of personalized medical
management.4,5 Novel nanoplatforms are being reported for all clinically relevant and
emergent biomedical imaging modalities.6–10 One particular promising new diagnostic
imaging technology is photoacoustic (PA) tomography (PAT).
The capabilities of ultrasound have recently been expanded by the development of
photoacoustic tomography also referred to as optoacoustic imaging.7 PAT enhances
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traditional ultrasound images by introducing optical acoustic stimulation to ultrasonic
imaging in order to reveal vascular patterns and oxygen saturation levels.8,11–18 To date,
PAT contrast agents have included single wall carbon nanotubes (SWNTs) targeting integral
αv,β3 and gold nanocages.9,10,14,19–21 In contradistinction to the homing individual gold
particles, we report a high payload gold nanorod (GNR) approach that provides marked
signal amplification for robust PAT imaging.
Gold particles are excitable in near-infrared (NIR) range within the “optical transmission
window” of the biological tissues (λ = 650–900 nm), which allows for deeper light
penetration, lower autofluorescence, and reduced light scattering. Unlike small molecule
fluorophores that can be excited in the NIR range using single- or two-photon
excitation.22–24 Gold particles are not susceptible to photobleaching, which has led to rapid
growth for their bioapplications for sensing, heating, labeling and delivery. In the present
approach to targeted PAT nanoagents, rod-shaped gold nanoparticles (i.e., nanorods) (GNR)
offer distinct optical properties resulting from two surface plasmon (SP) bands
corresponding to the transverse and longitudinal SP bands in the visible (λ = 520 nm) and
the NIR regions, respectively, are of particular interest.22–24 Owing to the presence of a
relatively large extinction coefficient, gold nanorods present ideal opportunities for
fluorescence, light scattering, and two-photon luminescence imaging. We hypothesized that
these properties would promote excellent contrast for photoacoustic bio-imaging in the NIR.
2. METHODS
2.1. Materials
Unless otherwise listed, all solvents and reagents were purchased from Aldrich Chemical
Co. (St. Louis, MO) and used as received. Anhydrous chloroform was purchased from
Aldrich Chemical Co. and distilled over calcium hydride prior to use. Biotinylated
dipalmitoyl-phosphatidylethanolamine and high purity egg yolk phosphatidylcholine were
purchased from Avanti Polar Lipids, Inc. Coated gold nanorods were purchased and used as
received from Nanopartz, Inc. Argon and nitrogen (UHP, 99.99%) were used for storage of
materials. The Spectra/Por membrane (Cellulose MWCO: 20000 Da) used for dialysis was
obtained from Spectrum Medical Industries, Inc. (Laguna Hills, CA). Glutaraldehyde,
osmium tetroxide, and uranyl acetate purchased from Electron Microscopy Sciences Tannic
acid purchased from Sigma-Aldrich. Polybed 812 was purchased from Polysciences.
2.2. Typical Procedure for Preparation of sGNR
In a typical experimental procedure, gold nanorods (axial diameter: 25 ± 5 nm, length: 80 ±
8 nm) were suspended in almond oil (4 mL) and vigorously vortexed to homogeneity. The
suspension was filtered through a small bed of cotton. The solvent was evaporated under
reduced pressure at 60 °C. the surfactant co-mixture included high purity egg yolk
phosphatidylcholine (90 mole%, 559 mg), cholesterol (8 mole%, 27 mg), and biotinylated-
dipalmitoyl phosphatidylethanolamine (2 mole%, 15 mg). The surfactant co-mixture was
dissolved in chloroform, filtered and evaporated under reduced pressure, dried in a 40 °C
vacuum oven overnight, and dispersed into water by probe sonication. This suspension is
combined with the gold nanorod-almond oil mixture (20% v/v), distilled deionized water
(77.3% w/v), and glycerin (1.7%, w/v). The mixture was continuously processed thereafter
at 20,000 PSI for 4 min with an S110 Microfluidics emulsifier (Microfluidics) at 4 °C. The
nanobeacons were dialyzed against water using a 20,000 Da MWCO cellulose membrane
for a prolonged period of time and then passed through a 0.45 μm Acrodisc Syringe filter.
To prevent bacterial growth the nanobeacons are stored under argon atmosphere typically at
4 °C.
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DLS (Dav/nm = 129±07 nm; AFM (Hav)/nm = 60 ± 24 nm; TEM (Dah)/nm = 105 ± 28 nm;
Zeta (ζ)/mV = −41 ±12 mV; PDI: 0.06 ± 0.02; ICP-MS = 8.12 μg of gold/g.
2.3. Photoacoustic Imaging System
A reflection-mode PA imaging system25 was used for all PA experiments (Scheme 1). A
tunable Ti:sapphire laser (LT-2211A, LOTIS TII) pumped by Q-switched Nd:YAG
(LS-2137, LOTIS II) laser was the light source, providing <15 ns pulse duration and a 10 Hz
pulse repetition rate. A dark-field ring-shaped illumination was used.25 The light energy on
the sample surface was controlled to conform to the American National Standards Institute
(ANSI) standard for maximum permissible exposure (MPE).27 A 5 MHz central frequency,
spherically focused (2.54 cm focus length, 1.91 cm diameter active area element, and 72%
bandwidth) ultrasonic transducer (V308, Panametrics-NDT) was used to acquire the
generated PA signals. The signal was then amplified by a low-noise amplifier (5072PR,
Panametrics-NDT), and recorded using a digital oscilloscope (TDS 5054, Tektronix) with a
50 mega-sampling rate. PA signal fluctuations due to pulse-to-pulse energy variation were
compensated by signals from a photodiode (DET110, Thorlabs), which sampled the energy
of each laser pulse.
A linear translation stage (XY-6060, Danaher Motion) was used for raster scanning to obtain
three-dimensional (3-D) PA data. A computer controlled the stage and synchronized it with
the data acquisition. To shorten the data acquisition time, a continuous scan was used
without signal averaging. An A-line (A-scan) was the PA signal obtained along the depth
direction at a single point. Multiple A-lines [acquired by a one-dimensional (1-D) scan] gave
a two-dimensional (2-D) B-scan. A 3-D image was acquired with a 2-D scan. A 1-D depth-
resolved image was obtained by multiplying the time axis of the initial A-scan (resolved in
time along the depth direction) by the speed of sound in soft tissue (~1500 m/s).
The scanning time depends on the laser pulse repetition rate (PRR), the scanning step size,
and the field of view (FOV). Typical values are a scanning step size for a 1-D scan = 0.1
mm, for a 2-D scan = 0.2 mm, a laser PRR = 10 Hz, and a FOV = 15 mm × 8 mm. The
acquisition time = ~14 min for a 3-D image. Please note that no signal averaging was done
for any of these images. The transducer was located inside a water container with an
opening of 5 cm × 5 cm at the bottom, sealed with a thin, clear membrane. The object was
placed under the membrane, and ultrasonic gel was used for coupling the sound.
2.4. Dynamic Light Scattering Measurements
Hydrodynamic diameter distribution and distribution averages for the sGNR and controls in
aqueous solutions were determined by dynamic light scattering. Hydrodynamic diameters
were determined using a Brookhaven Instrument Co. (Holtsville, NY) Model Zeta Plus
particle size analyzer. Measurements were made following dialysis (MWCO 10 kDa dialysis
tubing, Spectrum Laboratories, Rancho Dominguez, CA) of sGNR suspensions into
deionized water (0.2 μM). Nanorods were dialyzed into water prior to analysis. Scattered
light was collected at a fixed angle of 90°. A photomultiplier aperture of 400 mm was used,
and the incident laser power was adjusted to obtain a photon counting rate between 200 and
300 kcps. Only measurements for which the measured and calculated baselines of the
intensity autocorrelation function agreed to within +0.1 % were used to calculate
nanoparticle hydrodynamic diameter values. All determinations were made in multiples of
five consecutive measurements.
2.5. Electrophoretic Potential Measurements
Zeta potential (ζ) values for the sGNR were determined with a Brookhaven Instrument Co.
(Holtsville, NY) model Zeta Plus zeta potential analyzer. Measurements were made
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following dialysis (MWCO 20 kDa dialysis tubing, Spectrum Laboratories, Rancho
Dominguez, CA) of sGNR suspensions into water. Data were acquired in the phase analysis
light scattering (PALS) mode following solution equilibration at 25 °C. Calculation of ζ
from the measured nanoparticle electrophoretic mobility (μ) employed the Smoluchowski
equation: μ = εζ/η), where ε and η are the dielectric constant and the absolute viscosity of the
medium, respectively. Measurements of ζ were reproducible to within ±4 mV of the mean
value given by 16 determinations of 10 data accumulations.
2.6. UV-Visible Spectroscopy
Absorption measurements were made with a Shimadzu UV-1601 P/N 206–67001
spectrophotometer using Shimadzu-UV probe 2.21 software.
2.7. Transmission Electron Microscopy Measurements
Nanoparticles fixed with 2.5% gluturaldehyde in PBS for 30 minutes on ice, were spun at
top speed in a table top microfuge to form a tight pellet. After rinsing, the pellet was
sequentially stained with osmium tetroxide, tannic acid, and uranyl acetate; then dehydrated
and embedded in Polybed 812. Tissue was thin sectioned on a Reichert-Jung Ultracut, post
stained in uranyl acetate and lead citrate, viewed on a Zeiss 902 Electron Microscope, and
recorded with Kodak E.M. film.
2.8. Atomic Force Microscopy Measurements
A Digital Instruments Dimension 3000 series AFM (calibration date 08/2008) and standard
Veeco tapping mode silicon probes w/PtIr coating were used for scanning the samples.
In a typical methodology, aqueous suspensions of sGNR samples were dried in a class
10000-clean room on a clean glass slide for 3 h. Once dried, samples were placed on the
AFM and scanned. Pertinent scanning parameters were as follows: Resonant frequency
(probe): 60–80 kHz; Example of tip velocity: (4 μm/s for 2μm), (15 μm/s for 5 μm), (30 μm/
s for 10 μm). Aspect ratio: 1:1; Lift height: 20 nm; Resolution: 512 samples/line, 256 lines.
The average particle height (Hav) values and standard deviations were generated from the
analyses of a minimum of 100 particles from three micrographs.
2.9. Inductively Coupled Plasma-Optical Emission Spectroscopy
After imaging, the gold content of sGNR was analyzed by inductively coupled plasma-
optical emission spectroscopy (ICP-MS, SOP7040, Rev 9) conducted at the Exova (formerly
Bodycote), West Coast Analytical Service (WCAS), Santa Fe Springs, CA. Briefly, the
samples were analyzed by a Leeman Labs Direct Reading Echelle ICP-MS, or a DRE
instrument which was designed to handle sub-ppm to percent level metal concentrations.
3. RESULTS AND DISCUSSION
We report for the first time the development of a self-assembled, phospholipids-
encapsulated gold nanorod system, carrying multiple numbers of tiny rods for efficient NIR
imaging. The design of the self-assembled gold nanorods (sGNR) nanoparticles is based on
the self-assembly of natural amphilies in aqueous media to entrap hundreds of gold atoms. A
unique but simple strategy was followed that allowed us to entrap gold nanorods within the
core matrix to avoid unfavorable interactions with surface homing ligands or surrounding
plasma proteins. The self-assembled nanoparticles are encapsulated by phospholipids and
are constrained to the vasculature by size (>120 nm) to increase the target specificity and
avoid extravasation into non-target, non-clearance tissues. In a typical procedure, coated
gold nanorods (GNR; transmission electron microscope axial diameter: 25 ± 5 nm, length:
80 ± 8 nm; λLSPR: 750 nm, λTSPR: 530 nm) were dispersed in chloroform and premixed
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with vegetable oil (20% v/v almond oil) core matrix. The chloroform was removed under
reduced pressure at 45 °C to form a suspension of gold nanorods in vegetable oil-based core
matrix. In a parallel step, phospholipids were dissolved in chloroform, filtered and
evaporated to dryness under reduced pressure to form a lipid-thin film mixture. The
surfactant mixture comprised of phosphatidylcholine (PC) (99 mol%) and biotin-caproyl-PE
(1%) (Scheme 2) for future bioapplication. Lipid thin film mixture was dispersed in water
(0.2 μ.M) and homogenized with the GNR suspension at 20000 psi for 4 min to produce
self-assembled gold nanorods (Scheme 2). The particle thus formed was immediately
subjected to dialysis against nanopure water using cellulosic membrane (20 KDa MW CO).
This synthesis resulted in an encapsulation of ~ 127 gold atoms (ICP-MS = 8.12 μg of gold/
g) and nominally 800 biotins per nanoparticle for biotin-avidin interaction.
The sGNR particles, thus formed, had nominal hydrodynamic diameter of 129 ± 7 nm as
measured by dynamic light scattering (DLS). The polydispersity and zeta potential were
measured as 0.06 ± 0.02 and −41±12 mV (Brookhaven Instrument Co.), respectively. The
large negative zeta potential implied successful phospholipids encapsulation and high
colloidal stability of these nanoparticles. The dehydrated state diameter (Dav) and height
parameters (Hav) of the sGNR were 105 ± 28 and 60 ± 24 nm, as measured by transmission
electron microscopy (TEM) and atomic force microscopy measurements (AFM) respectively
(Fig. 1). The discrepancies in hydrodynamic diameter (DLS) and height values (AFM) was
presumably due to the partial flattening of the nanoparticles on the glass substrates,which is
indicative of the soft, compressible nature of these nanoparticles. TEM images of the sGNR
confirmed the presence of multiple GNRs within the phospholipids encapsulated particles.
AFM images pointed towards the spherical nature of the particles.
To assess the application of sGNR as NIR imaging probes in vitro, we attempted to detect
the PA signals of sGNR from a tube (Silastic® laboratory tubing, Dow Corning Corp., with
300 μm inner diameter and 640 μm outside diameter) using a photoacoustic imaging system.
Figure 2(a) shows the PA signals (excitation wavelength = 728 nm) obtained from a tube
filled with sGNR (red) and a tube filled with water (blue). A very weak signal from the tube
filled with water (blue) confirmed that there was no significant PA signal generated from
either water or the tube surface and all the signals generated from the tube filled with sGNR
were coming from the sGNR itself. At this excitation wavelength, the peak-to-peak PA
signal amplitude obtained from sGNR was about 325 mV, compared to only 37 mV PA
signal generated from the tube filled with water. The PA spectrum of the sGNR over the
728–810 nm window is shown in Figure 2(b). It can be seen that as the light wavelength
increases, the absorptioncoefficient of sGNR decreases. Figure 2(c) shows a maximum
amplitude projection (MAP)18 photoacoustic image of the same tube filled with sGNR
(wavelength = 747 nm). Figure 2(d) shows the B-scan PA image along the dotted line in 2(c)
and the strong PA signal from sGNR is marked with an arrow.
4. CONCLUSIONS
The strong PA signal from sGNR in the NIR region indicates the potential for molecular PA
imaging of this platform. This work introduced the concept of a “soft” type self-assembled
gold nanorod contrast agent for efficient NIR optical detection. Further in vitro and in vivo
works are warranted to realize the full potential of the platform to improve photoacoustic
detection of diseased sites.
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Refer to Web version on PubMed Central for supplementary material.
Pan et al. Page 5
J Nanosci Nanotechnol. Author manuscript; available in PMC 2011 May 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Acknowledgments
The financial support from the AHA under grant number 0835426N (Dipanjan Pan), from NIH under grant
numbers NS059302, CA119342 (Gregory M. Lanza), HL073646 (Samuel A. Wickline), U54 CA136398,
R01EB000712, R01NS046214, EB008085 (Lihong V. Wang) is greatly appreciated. Lihong V. Wang has a
financial interest in Microphotoacoustic, Inc. and Endra, Inc., which, however, did not support this work.
References and Notes
1. Pan D, Lanza GM, Wickline SA, Caruthers SD. Eur J Radiol. 2009; 70:274. [PubMed: 19268515]
2. Wang L, O’Donoghue MB, Tan W. Nanomedicine. 2006; 1:413. [PubMed: 17716144]
3. Nie S, Xing Y, Kim GJ, Simons JW. Annu Rev Biomed Eng. 2007; 9:257. [PubMed: 17439359]
4. Cai W, Chen X. Small. 2007; 3:1840. [PubMed: 17943716]
5. Zharov VP, Kim JW, Curiel DT, Everts M. Nanomedicine. 2005; 1:326. [PubMed: 17292107]
6. Chen W. J Nanosci Nanotechnol. 2008; 8:1019. [PubMed: 18468106]
7. Li ML, Oh JT, Xie XY, Ku G, Wang W, Li C, Lungu G, Stoica G, Wang LHV. Proc IEEE. 2008;
96:481.
8. Wang XD, Pang YJ, Ku G, Xie XY, Stoica G, Wang LHV. Nat Biotechnol. 2003; 21:803. [PubMed:
12808463]
9. Agarwal A, Huang SW, O’Donnell M, Day KC, Day M, Kotov N, Ashkenazi S. J Appl Phys. 2007;
102:064701.
10. De La Zerda A, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma TJ,
Oralkan O, Cheng Z, Chen XY, Dai HJ, Khuri-Yakub BT, Gambhir SS. Nat Nanotechnol. 2008;
3:557. [PubMed: 18772918]
11. Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, Billan S, Abdah-Bortnyak R, Kuten
A, Haick H. Nat Nanotechnol. 2009; 4:669. [PubMed: 19809459]
12. Kim JW, Galanzha EI, Shashkov EV, Moon HM, Zharov VP. Nat Nanotechnol. 2009; 4:688.
[PubMed: 19809462]
13. Song KH, Stein EW, Margenthaler JA, Wang LHV. J Biomed Opt. 2008; 13:054033. [PubMed:
19021413]
14. Song KH, Kim CH, Cobley CM, Xia YN, Wang LHV. Nano Lett. 2009; 9:183. [PubMed:
19072058]
15. Kruger RA, Liu PY, Fang YR, Appledorn CR. Med Phys. 1995; 22:1605. [PubMed: 8551984]
16. Hoelen CGA, de Mul FFM, Pongers R, Dekker A. Opt Lett. 1998; 23:648. [PubMed: 18084605]
17. Oraevsky AA, Savateeva EV, Solomatin SV, Karabutov AA, Andreev VG, Gatalica Z,
Khamapirad T, Henrichs PM. Proc SPIE. 2002; 4618:81.
18. Zhang HF, Maslov K, Stoica G, Wang LHV. Nat Biotechnol. 2006; 24:848. [PubMed: 16823374]
19. Wang YW, Xie XY, Wang XD, Ku G, Gill KL, O’Neal DP, Stoica, Wang LHV. Nano Lett. 2004;
4:1689.
20. Pramanik M, Swierczewska M, Green D, Sitharaman B, Wang LHV. J Biomed Opt. 2009;
14:034018. [PubMed: 19566311]
21. Pan D, Pramanik M, Senpan A, Yang X, Song KH, Scott MJ, Zhang, Gaffney PJ, Wickline SA,
Wang LHV, Lanza GM. Angew Chem Intl Ed. 2009; 48:4170.
22. Kojima H. Yakugaku Zasshi. 2008; 128:1653. [PubMed: 18981701]
23. Ntziachristos V, Bremer C, Weissleder R. Eur Radiol. 2003; 13:195. [PubMed: 12541130]
24. Rostro-Kohanloo BC, Bickford LR, Payne CM, Day ES, Anderson LJ, Zhong M, Lee S, Mayer
KM, Zal T, Adam L, Dinney CP, Drezek RA, West JL, Hafner JH. Nanotechnology. 2009;
20:434005. [PubMed: 19801751]
25. Song KH, Wang LHV. J Biomed Opt. 2007; 12:060503. [PubMed: 18163798]
26. Maslov K, Stoica G, Wang LHV. Opt Exp. 2005; 30:625.
27. Laser Institute of America, American National Standard for Safe Use of Lasers ANSI Z136.1–
2000. American National Standards Institute, Inc; New York, NY: 2000.
Pan et al. Page 6
J Nanosci Nanotechnol. Author manuscript; available in PMC 2011 May 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 1.
Anhydrous state morphology of the sGNR nanoparticles: (a) AFM images of sGNR drop
deposited over glass; (b) TEM image of GNR drop deposited over Ni-grid; (c–d) TEM
images of, sGNR drop deposited over Ni-grid; (e–h) specific sections of sGNR showing
multiple localization of gold nanorods encapsulated by phospholipids.
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Fig. 2.
Photoacoustic imaging of sGNR nanoparticles: (a) PA signals generated from a tube
(Silastic® laboratory tubing, Dow Corning Corp., I.D. 300μm. O.D. 640 μm) filled with
sGNR; (b) PA spectrum of sGNR in the NIR window (728–810 nm); (c) Maximum
amplitude projection (MAP)18 photoacoustic image of a tube filled with sGNR; (b) PA B-
scan image along the dotted line in (c), with the bright spot showing the PA signal
originating from the tube filled with sGNR.
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Scheme 1.
Schematic diagram of the reflection-mode photoacoustic system.
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Scheme 2.
Synthesis of self-assembled gold nano rods: (i) chloroform (ii) evaporation of chloroform
under reduced pressure, 45 °C, thin film formation from phospholipids mixture; (iii)
suspended with vegetable oil (2 w/v%), (iv) vortex, mixing; evaporation of chloroform
under reduced pressure, 45 °C; (v) self-assembly (dispersion) in water by probe sonication at
ambient temperature; (vi) homogenization, 20000 psi, 4 min, 0 °C; (vii) dialysis against
nanopure water, 20 KDa MW CO cellulosic membrane, (a) UV-vis spectrum of gold
nanorods showing LSPR and TSPR bands at 750 nm and 530 nm respectively.
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